Chloride Channel ClC- 2 Enhances Intestinal Epithelial Tight Junction Barrier Function Via Regulation of Caveolin-1 and Caveolar Trafficking of Occludin
Overview
Authors
Affiliations
Previous studies have demonstrated that the chloride channel ClC-2 plays a critical role in intestinal epithelial tight junction (TJ) barrier function via intracellular trafficking of TJ protein occludin. To study the mechanism of ClC-2-mediated TJ barrier function and intracellular trafficking of occludin, we established ClC-2 over-expressing Caco-2 cell line (Caco-2) by full length ClC-2 ORF transfection. ClC-2 over-expression (Caco-2) significantly enhanced TJ barrier (increased TER by ≥2 times and reduced inulin flux by 50%) compared to control Caco-2 cells. ClC-2 over-expression (Caco-2) increased occludin protein level compared to control Caco-2 cells. Surface biotinylation assay revealed reduced steady state endocytosis of occludin in Caco-2 cells. Furthermore, ClC-2 over-expression led to reduction in caveolin-1 protein level and diminishment of caveolae assembly. Caveolae disruption increased TJ permeability in control but not ClC-2 over-expressing Caco-2 cells. Selective ClC-2 channel blocker GaTx2 caused an increase in caveolin-1 protein level and reduced occludin level. Delivery of cell permeable caveolin-1 scaffolding domain reduced the occludin protein level. Over all, these results suggest that ClC- 2 enhances TJ barrier function in intestinal epithelial cells via regulation of caveolin-1 and caveolae-mediated trafficking of occludin.
Chloride channels and mast cell function: pioneering new frontiers in IBD therapy.
Aljameeli A, Alsuwayt B, Bharati D, Gohri V, Mohite P, Singh S Mol Cell Biochem. 2025; .
PMID: 40038149 DOI: 10.1007/s11010-025-05243-w.
Ion channels research in hPSC-RPE cells: bridging benchwork to clinical applications.
Xu P, Zou W, Yin W, Chen G, Gao G, Zhong X J Transl Med. 2024; 22(1):1073.
PMID: 39604931 PMC: 11600670. DOI: 10.1186/s12967-024-05769-5.
Mehrotra S, Kalyan Bg P, Nayak P, Joseph A, Manikkath J Adv Pharm Bull. 2024; 14(1):11-33.
PMID: 38585454 PMC: 10997937. DOI: 10.34172/apb.2024.009.
Xu M, Neelands T, Powers A, Liu Y, Miller S, Pintilie G Elife. 2024; 12.
PMID: 38345841 PMC: 10942593. DOI: 10.7554/eLife.90648.
Yan Q, Li T, Zhang Y, Zhao X, Wang Q, Yuan L Animals (Basel). 2024; 14(2).
PMID: 38254351 PMC: 10812639. DOI: 10.3390/ani14020183.